Evidence map›Paper›PMID 28638871›Full record

ArticleAfrican journal of traditional, complementary, and alternative medicines : AJTCAM2017

EFFECT OF YISHENJIANPI RECIPE ON SEMEN QUALITY AND SPERM MITOCHONDRIA IN MICE WITH OLIGOASTHENOZOOSPERMIA INDUCED BY TRIPTERYGIUM GLYCOSIDES.

Wen Sheng, Yao-Sheng Zhang, Yue-Qing Li, Xiao-Ni Wu, Li-Min Chai, Li-Feng Yue, Juan-Liu, Jin Ding, Xian-Rui Li, Meng Chen and 1 more

Open access · diamondAbstract read
In one paragraph

Article in African journal of traditional, complementary, and alternative medicines : AJTCAM, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Impact of Moriamin Forte on Testicular and Epididymal Damage in Rats with Oligoasthenospermia.Evidence-based complementary and alternative medicine : eCAM · 2021
    Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Wen ShengDepartment of Andrology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Yao-Sheng ZhangDepartment of Andrology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Yue-Qing LiDepartment of Andrology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Xiao-Ni WuDepartment of General Surgery, The Fourth Hospital of Changsha, Hunan Normal University, Changsha, China.
Li-Min ChaiDepartment of Andrology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Li-Feng YueDepartment of Andrology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Juan-LiuDepartment of Andrology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Jin DingDepartment of Andrology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Xian-Rui LiDepartment of Andrology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Meng ChenSchool of Preclinical Medicine, Beijing University of Chinese Medicine, Beijing, China.
Jian-Wei ShangDepartment of Andrology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine · CNHunan Normal University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundKidney tonifying - spleen strengthening method being one of the modalities for treatment of astheno-oligozoospermia is currently commonly used in the clinical setting. To investigate the mechanism of YiShenJianPi (YSJP) Recipe, used in Traditional Chinese Medicine to benefit "the kidney" and strengthen "the spleen". MATERIALS AND

methodsOligoasthenozoospermia, male BALB/c mice were randomly divided into normal control, disease model, positive control, low-dosage and high-dosage groups. Oligoasthenozoospermia was induced by tripterygium glucosides intragastric administration before treatment started. Through using computer-aided sperm analysis to test the changes in sperm quality, utilizing flow cytometry to test the percentage of sperm with normal mitochondrial transmembrane potential (JC-1 + %), utilizing X-ray microscopy to observe epididymal sperm ultra-microstructure placing special emphasis and photographing the differences in mitochondria of the flagellum region.

resultsCompared with DM, sperm quality of the treated mice was significantly better (P<0.05, respectively). Compared with PC, the LD group had significantly better quality sperms, while the parameters in the HD group were numerically better. Compared with NC, all other groups had significantly lower percentage of sperms with normal mitochondrial membrane potential. In PC, LD and HD groups, the percentage of sperms with normal mitochondrial membrane potential was significantly higher than that of D. The 9+9+2 mitochondrial sheath structure was complete in NC but damaged in DM. In the treatment groups, this structure was fairly clear.

conclusionYSJP improved semen quality with oligoasthenozoospermia by improving sperm mitochondrial membrane potential and restoring sperm mitochondrial ultrastructure.

Indexed as

AnimalsAsthenozoospermiaDrugs, Chinese HerbalGlycosidesHumansMaleMembrane Potential, MitochondrialMiceMice, Inbred BALB CMitochondriaSpermatozoaSperm MotilityTripterygiumDrugs, Chinese HerbalGlycosidesmitochondrial membrane potentialmitochondrial ultrastructureoligoasthenozoospermiasemen qualitytraditional Chinese medicine

Identifiers

PMID28638871
PMCPMC5471487
OpenAlexW2624567318

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.